The India Cancer Diagnostics market was valued at US$ XX Mn in 2018 and is expected to reach US$ XX Mn by 2026, growing at a CAGR of 12.6% during the forecast period.
Cancer is a disease in which tumors are formed by the uncontrolled division of cells in a part of the body. Depending on the site of the tumor, cancer can be diagnosed via a variety of tests, including but not limited to Computed Tomography (CT) scans, biopsies, Magnetic Resonance Imaging (MRI), various endoscopy, mammography, tumor marker tests, and complete blood counts.
The increasing incidence of cancer in India, coupled with the increasing demand for early and accurate diagnosis, is driving the growth of the cancer diagnostics market in India. Apart from this, the increasing investment by the major cancer medical diagnostic device providers is also expected to drive the market.
However, the lack of infrastructure in rural areas, the high cost associated with the diagnosis of cancer, and lack of awareness regarding the disease are expected to impede the growth of the cancer diagnostics market.
Biopsy tests dominated the market in the year 2018
Based on test type, the cancer diagnostics market has been segmented into Platform-based testing, biopsy tests, and other tests. The biopsy tests segment dominated the market in the year 2018, with a market share of over 50%. Biopsies are the most commonly done tests for the diagnosis of cancer.
The platform-based testing segment is expected to grow at the highest CAGR during the forecast period. While the growth in the biopsy tests segment is mainly due to the growth of the population, the growth in the platform-based testing segment is primarily driven by the high accuracy of the tests.
Based on clinical setting, the hospitals segment dominated the market, whereas the medical laboratories segment is expected to grow at a high CAGR during the forecast period.
The major players operating in the cancer diagnostics market are Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Becton Dickinson and Company, and Biomerieux S.A., amongst others. Most of the players in this market are introducing tests specifically for the Indian market.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Approach Adopted
1.3.4.1 Top-Down Approach
1.3.4.2 Bottom-Up Approach
1.3.5 Assumptions
1.4 Market Segmentation Scope
Chapter 2 Executive Summary
2.1 Market Summary
2.1.1 India Cancer Diagnostics Market, 2016-2026, (US$ Mn)
2.1 Market Snapshot: India Cancer Diagnostics Market
2.2 Market Dynamics
2.3 India Cancer Diagnostics Market, by Segment, 2018
2.3.1 India Cancer Diagnostics Market, by Test Type, 2018 (US$ Mn)
2.3.2 India Cancer Diagnostics Market, by Clinical Setting, 2018 (US$ Mn)
Chapter 3 Market Dynamics
3.1 Market Overview
3.2 Market Drivers
3.2.1 Increasing incidence of cancer
3.2.2 Increasing demand for early and accurate diagnosis and precision medicine
3.2.3 Increasing investment by the major cancer medical diagnostic device providers
3.3 Market Restraints
3.3.1 High Cost associated with diagnosis of cancer
3.3.2 Lack of awareness regarding the disease
3.3.3 Lack of infrastructure in rural areas
3.4 Market Opportunities
3.4.1 Technological Advancements
3.4.2 Opportunity 2
Chapter 4 India Cancer Diagnostics Market, by Test Type
4.1 Market Overview, by Test Type
4.1.1 India Cancer Diagnostics Market, by Test Type, 2016-2026 (US$ Mn)
4.1.2 Incremental Opportunity, by Test Type, From 2018-2026
4.2 Biopsy
4.2.1 India Cancer Diagnostics Market, by Biopsy, 2016-2026, (US$ Mn)
4.3 Platform-based testing
4.3.1 India Cancer Diagnostics Market, by Platform-based testing, 2016-2026, (US$ Mn)
4.4 Others
4.4.1 India Cancer Diagnostics Market, by Others, 2016-2026, (US$ Mn)
Chapter 5 India Cancer Diagnostics Market, by Clinical Setting
5.1 Market Overview, by Clinical Setting
5.1.1 India Cancer Diagnostics Market, by Clinical Setting, 2016-2026 (US$ Mn)
5.1.2 Incremental Opportunity, by Clinical Setting, From 2018-2026
5.2 Hospitals
5.2.1 India Cancer Diagnostics Market, by Hospitals, 2016-2026, (US$ Mn)
5.3 Medical Laboratories
5.3.1 India Cancer Diagnostics Market, by Medical Laboratories, 2016-2026, (US$ Mn)
Chapter 6 Competitive Intelligence
6.1 Market Positioning of Key Players, 2018
6.2 Market Players Mapping
6.2.1 By Test Type
6.3 Strategies Adopted by Key Market Players
6.4 Recent Developments in the Market
6.4.1 Mergers & Acquisitions, Partnership, New Product Developments
Chapter 7 Company Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Overview
7.1.2 Key Stakeholders/Person in Roche Diagnostics
7.1.3 Roche Diagnostics Products Portfolio
7.1.4 Roche Diagnostics Financial Overview
7.1.5 Roche Diagnostics News/Recent Developments
7.2 Becton Dickinson and Company
7.2.1 Becton Dickinson and Company Overview
7.2.2 Key Stakeholders/Person in Becton Dickinson and Company
7.2.3 Becton Dickinson and Company Products Portfolio
7.2.4 Becton Dickinson and Company Financial Overview
7.2.5 Becton Dickinson and Company News/Recent Developments
7.3 Beckman Coulter
7.3.1 Beckman Coulter Overview
7.3.2 Key Stakeholders/Person in Beckman Coulter
7.3.3 Beckman Coulter Products Portfolio
7.3.4 Beckman Coulter Financial Overview
7.3.5 Beckman Coulter News/Recent Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Overview
7.4.2 Key Stakeholders/Person in Abbott Laboratories
7.4.3 Abbott Laboratories Products Portfolio
7.4.4 Abbott Laboratories Financial Overview
7.4.5 Abbott Laboratories News/Recent Developments
7.5 Biomerieux S.A.
7.5.1 Biomerieux S.A. Overview
7.5.2 Key Stakeholders/Person in Biomerieux S.A.
7.5.3 Biomerieux S.A. Products Portfolio
7.5.4 Biomerieux S.A. Financial Overview
7.5.5 Biomerieux S.A. News/Recent Developments
TABLE 1 Market Snapshot: India Cancer Diagnostics Market Value
TABLE 2 India Cancer Diagnostics Market, by Test Type, 2016-2026 (US$ Mn)
TABLE 3 India Cancer Diagnostics Market, by Clinical Setting, 2016-2026 (US$ Mn)
TABLE 4 Market Players Mapping – By Test Type
TABLE 5 Strategies Adopted by Key Market Players
TABLE 6 Mergers & Acquisitions, Partnership, New Product Developments
TABLE 7 Roche Diagnostics Overview
TABLE 8 Key Stakeholders/Person in Roche Diagnostics
TABLE 9 Roche Diagnostics Product Portfolio
TABLE 10 Roche Diagnostics News/Recent Developments
TABLE 11 Becton Dickinson and Company Overview
TABLE 12 Key Stakeholders/Person in Becton Dickinson and Company
TABLE 13 Becton Dickinson and Company Product Portfolio
TABLE 14 Becton Dickinson and Company News/Recent Developments
TABLE 15 Beckman Coulter Overview
TABLE 16 Key Stakeholders/Person in Beckman Coulter
TABLE 17 Beckman Coulter Product Portfolio
TABLE 18 Beckman Coulter News/Recent Developments
TABLE 19 Abbott Laboratories Overview
TABLE 20 Key Stakeholders/Person in Abbott Laboratories
TABLE 21 Abbott Laboratories Product Portfolio
TABLE 22 Abbott Laboratories News/Recent Developments
TABLE 23 Biomerieux S.A. Overview
TABLE 24 Key Stakeholders/Person in Biomerieux S.A.
TABLE 25 Biomerieux S.A. Product Portfolio
TABLE 26 Biomerieux S.A. News/Recent Developments
